Literature DB >> 12115567

Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells.

Aubri L Charboneau1, Vinita Singh, Tingxi Yu, Irene F Newsham.   

Abstract

The differentially expressed in adenocarcinoma of the lung (DAL-1) gene, which shares significant homology with members of the 4.1/ezrin/radixin/moesin/neurofibromatosis 2 (ERM/NF2) protein family, has previously been shown to suppress growth in lung cancer cell lines. This gene localizes to chromosome band 18p11.3, which undergoes loss of heterozygosity (LOH) in nonsmall cell lung carcinomas and a significant proportion of ductal carcinomas in situ (DCIS) of the breast. This finding suggests that alteration of gene(s) (possibly DAL-1) within this chromosomal region may be important early in the progression of breast disease. We generated MCF-7 cell lines expressing DAL-1 constitutively or under the control of an inducible promoter and analyzed the effect of DAL-1 expression on growth. These investigations revealed that the DAL-1 protein suppresses the growth of MCF-7 cells and may do so in part through the induction of apoptosis. In addition, expression of DAL-1 increased attachment of these cells to a variety of extracellular matrices. This is the first evidence that the DAL-1 protein functions at the interface between cell adhesion and apoptosis in controlling cell growth. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115567     DOI: 10.1002/ijc.10470

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Allelotyping for loss of heterozygosity on chromosome 18 in gastric cancer.

Authors:  Jing-Cui Yu; Kai-Lai Sun; Buo Liu; Song-Bin Fu
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

2.  Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs.

Authors:  Christian Huisman; Monique G P van der Wijst; Fahimeh Falahi; Juul Overkamp; Gellért Karsten; Martijn M Terpstra; Klaas Kok; Ate G J van der Zee; Ed Schuuring; G Bea A Wisman; Marianne G Rots
Journal:  Epigenetics       Date:  2015-04-01       Impact factor: 4.528

3.  LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions.

Authors:  Ravindra Varma Polisetty; Poonam Gautam; Rakesh Sharma; H C Harsha; Sudha C Nair; Manoj Kumar Gupta; Megha S Uppin; Sundaram Challa; Aneel Kumar Puligopu; Praveen Ankathi; Aniruddh K Purohit; Giriraj R Chandak; Akhilesh Pandey; Ravi Sirdeshmukh
Journal:  Mol Cell Proteomics       Date:  2012-01-04       Impact factor: 5.911

Review 4.  Tumor suppressor role of protein 4.1B/DAL-1.

Authors:  Zi Wang; Ji Zhang; Mao Ye; Min Zhu; Bin Zhang; Mridul Roy; Jing Liu; Xiuli An
Journal:  Cell Mol Life Sci       Date:  2014-09-03       Impact factor: 9.261

5.  Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.

Authors:  Dimitra Dafou; Barbara Grun; John Sinclair; Kate Lawrenson; Elizabeth C Benjamin; Estrid Hogdall; Susanne Kruger-Kjaer; Lise Christensen; Heidi M Sowter; Ahmed Al-Attar; Richard Edmondson; Stephen Darby; Andrew Berchuck; Peter W Laird; C Leigh Pearce; Susan J Ramus; Ian J Jacobs; Simon A Gayther
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

Review 6.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

7.  Loss of expression of the differentially expressed in adenocarcinoma of the lung (DAL-1) protein is associated with metastasis of non-small cell lung carcinoma cells.

Authors:  Yajie Zhang; Ruobing Xu; Guiqin Li; Xiaobin Xie; Jie Long; Hongyan Wang
Journal:  Tumour Biol       Date:  2012-07-11

8.  Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium.

Authors:  Nobuhiko Ohno; Nobuo Terada; Shin-ichi Murata; Hisashi Yamakawa; Irene F Newsham; Ryohei Katoh; Osamu Ohara; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2004-10-29       Impact factor: 4.304

9.  4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.

Authors:  Qin Yang; Min Zhu; Zi Wang; Hui Li; Weihua Zhou; Xiaojuan Xiao; Bin Zhang; Weixin Hu; Jing Liu
Journal:  Tumour Biol       Date:  2016-07-22

10.  Protein 4.1B suppresses prostate cancer progression and metastasis.

Authors:  Sunny Y Wong; Herbert Haack; Joseph L Kissil; Marc Barry; Roderick T Bronson; Steven S Shen; Charles A Whittaker; Denise Crowley; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.